Abstract

Your attention is given to the clinical observation of a patient with recurrent liposarcoma of the left upper limb. According to vital indications with palliative purpose, the patient underwent surgery in the Oncology Department of surgical methods of treatment of FSBI SSC FMBC named after A.I. Burnazyan, FMBA of Russia. The operation was carried out in the amount of interscapularthoracic amputation on the left with resection of the left clavicle, plasty of the defect of rotary musclefat flap on a vascular pedicle after previous surgical treatment previous year in the amount of assertional the left upper extremity with the plastic of the wound defect myofascial flap on a vascular pedicle. Attempts to palliative embolization of blood vessels supplying the tumor node were unsuccessful, and the only option to provide medical care at this stage was surgical treatment. It should also be noted that the patient has a history of cancer of the left breast, in connection with which she was treated about 10 years ago. Currently, the patient is under our dynamic control and is undergoing adjuvant radiotherapy. The postoperative period was uneventful.

Highlights

  • Саркомы мягких тканей – редкая группа опухолей

  • Несмотря на значительные успехи в лечении сарком мягких тканей, частота возникновения локальных рецидивов после иссечения первичной опухоли сопоставима с данными полувековой давности [7]

  • К. Анализ факторов риска появления рецидивов сарком мягких тканей на основе клинико-морфологических характеристик опухоли

Read more

Summary

Introduction

Хирургическое лечение является стандартом лечения всех сарком низкой степени злокачественности, включая и липосаркомы. Несмотря на значительные успехи в лечении сарком мягких тканей, частота возникновения локальных рецидивов после иссечения первичной опухоли сопоставима с данными полувековой давности [7]. Посвященных злокачественным опухолям мягких тканей, указывается на высокую частоту рецидивов, варьирующуюся в широких пределах – от 25 до 60% случаев, а в зависимости от характера лечения первичной опухоли и особенностей течения заболевания достигающую и 90% [8].

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.